Randomized Trial of Individualized Texting for Adherence Building (iTAB) Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals: The iM-PrEPT Study : JAIDS Journal of Acquired Immune Deficiency Syndromes

Secondary Logo

Journal Logo

You can read the full text of this article if you:

Access through Ovid
Prevention Research

Randomized Trial of Individualized Texting for Adherence Building (iTAB) Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals: The iM-PrEPT Study

Morris, Sheldon R. MD, MPHa; Jain, Sonia PhDa; Blumenthal, Jill MDa; Bolan, Robert MDb; Dubé, Michael P. MDc; Henderson, Philip MDd; Corado, Katya MDe; Sun, Shelly MSa; He, Feng MSa; Chow, Karen BSca; Burke, Leah MPHa; Anderson, Peter L. PharmDf; Moore, David J. PhDa

Author Information
JAIDS Journal of Acquired Immune Deficiency Syndromes: December 15, 2022 - Volume 91 - Issue 5 - p 453-459
doi: 10.1097/QAI.0000000000003091
  • Buy

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.